Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats

Autor: Šárka Jíchová, Janusz Sadowski, Zuzana Husková, Elzbieta Kompanowska-Jezierska, Libor Kopkan, John R. Falck, Herbert J. Kramer, Zdenka Vernerová, Petr Kujal, Luděk Červenka, Rami N. Reddy, Šárka Doleželová, Jan Neckář, John D. Imig
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Popis: OBJECTIVE We evaluated the therapeutic effectiveness of a new, orally active epoxyeicosatrienoic acid analog (EET-A) in rats with angiotensin II (ANG II)-dependent malignant hypertension. METHODS Malignant hypertension was induced in Cyp1a1-Ren-2 transgenic rats by activation of the renin gene using indole-3-carbinol (I3C), a natural xenobiotic. EET-A treatment was started either simultaneously with I3C induction process (early treatment) or 10 days later during established hypertension (late treatment). Blood pressure (BP) (radiotelemetry), indices of renal and cardiac injury, and plasma and kidney levels of the components of the renin-angiotensin system (RAS) were determined. RESULTS In I3C-induced hypertensive rats, early EET-A treatment attenuated BP increase (to 175 ± 3 versus 193 ± 4 mmHg, P
Databáze: OpenAIRE